Current and future management approaches for rheumatoid arthritis
1Leiden University Medical Center, Leiden, The Netherlands. f.c.breedveld@lumc.nl
Arthritis Research
|July 12, 2002
Summary
Early rheumatoid arthritis (RA) management now uses aggressive therapy with disease-modifying antirheumatic drugs (DMARDs) and biologics to prevent joint damage. Early diagnosis and treatment are key for better patient outcomes.
Area of Science:
- Rheumatology
- Immunology
- Pharmacology
Background:
- Rheumatoid arthritis (RA) management has evolved significantly.
- The focus is shifting towards early and aggressive therapeutic interventions.
Purpose of the Study:
- To review the current landscape of early rheumatoid arthritis treatment.
- To highlight the role of new therapeutic agents in preventing joint damage.
Main Methods:
- Review of recent advancements in disease-modifying antirheumatic drugs (DMARDs).
- Discussion of biologic agents, including anti-tumor necrosis factor (TNF) therapies and interleukin (IL)-1 antagonists.
- Consideration of future nonbiologic agents targeting signaling pathways.
Main Results:
- Early diagnosis and treatment are crucial for preventing RA-related structural joint damage.
- Combination DMARD regimens and biologic agents offer viable options for early RA treatment.
- New biologic and future nonbiologic agents are poised to transform RA management.
Conclusions:
- Aggressive early treatment strategies are essential in managing rheumatoid arthritis.
- Biologic agents represent a significant advancement in RA therapy.
- Ongoing research into novel therapeutic targets promises further improvements in RA care.
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:22Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
01:17Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...